Targeting tumor-associated macrophages with STING agonism improves the antitumor efficacy of osimertinib in a mouse model of <i>EGFR-</i>mutant lung cancer.

Front Immunol · 2023 · PMC9933873 · PMID 36817465

Europe PMC DOI

hedged sentence

0.0670

closest p · 1.3× alpha

0.0670

boldest claim

The sentences

a trend toward significancep = 0.067so close (0.05 < p ≤ 0.1)

Moreover, the increase of T cell inflamed score upon EGFR-TKI treatment and longer TTP exhibited a correlation with a trend toward significance ( p = 0.067 , Figure 1F ).

also in 3,729 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.